Latest Articles
RNA Chemical Tag Drives Endometrial Cancer Through a DNA Repair Protein, Study Finds - Bioengineer.org
RNA Chemical Tag Drives Endometrial Cancer Through a DNA Repair Protein, Study Finds Bioengineer.org
Published: Oct. 2, 2026, 6:10 p.m.
RNA Chemical Tag Drives Endometrial Cancer Through a DNA Repair Protein, Study Finds - bioengineer.org
RNA Chemical Tag Drives Endometrial Cancer Through a DNA Repair Protein, Study Finds bioengineer.org
Published: Oct. 2, 2026, 6:10 p.m.
DNA Droplets That Work With Light - The National Tribune
DNA Droplets That Work With Light The National Tribune
Published: June 26, 2026, 3:06 a.m.
Standard cell-free DNA analysis vs Unity Confirm for high-risk prenatal screening results - Contemporary OB/GYN
Standard cell-free DNA analysis vs Unity Confirm for high-risk prenatal screening results Contemporary OB/GYN
Published: June 8, 2026, 12:09 p.m.
Vaginal DNA Assay Shows Promise - Conexiant
Vaginal DNA Assay Shows Promise Conexiant
Published: May 7, 2026, 8:05 p.m.
Kristina Lindemann: New Insights Into ctDNA Monitoring in Endometrial Cancer - Oncodaily
Kristina Lindemann: New Insights Into ctDNA Monitoring in Endometrial Cancer Oncodaily
Published: May 1, 2026, 1:44 p.m.
Design and evaluation of a custom circulating tumour DNA assay to detect endometrial cancer recurrence - Nature
Design and evaluation of a custom circulating tumour DNA assay to detect endometrial cancer recurrence Nature
Published: March 23, 2026, 8:51 a.m.
New DNA Sequence Motifs Identified as Regulators of Gene Expression in T Cells - geneonline.com
New DNA Sequence Motifs Identified as Regulators of Gene Expression in T Cells geneonline.com
Published: Jan. 9, 2026, 3:41 p.m.
Kristina Lindemann: The Prognostic Value of Preoperative ctDNA Assessment in Endometrial Cancer - Oncodaily
Kristina Lindemann: The Prognostic Value of Preoperative ctDNA Assessment in Endometrial Cancer Oncodaily
Published: Jan. 3, 2026, 8:59 p.m.
Medicenna Updates MDNA11 Clinical Trial Results at the ESMO-IO Congress 2025, Further Bolstering its Anti-Tumor Activity in Advanced Solid Tumors - The Manila Times
Medicenna Updates MDNA11 Clinical Trial Results at the ESMO-IO Congress 2025, Further Bolstering its Anti-Tumor Activity in Advanced Solid Tumors The Manila Times
Published: Dec. 10, 2025, 12:40 p.m.
Link copied to clipboard!